Gestational hypothyroxinemia and the beneficial effects of early dietary iodine fortification.
Daniel
D
Glinoer
Joanne
J
Rovet
D002657:Child Development / Q000187:drug effects; D003677:Deficiency Diseases / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D019587:Dietary Supplements; D004334:Drug Administration Schedule; D005260:Female; D005865:Gestational Age; D006801:Humans; D007223:Infant; D018730:Infant Behavior / Q000187:drug effects; D007455:Iodine / Q000008:administration & dosage* / Q000097:blood / Q000172:deficiency; D007774:Lactation; D009420:Nervous System / Q000187:drug effects / Q000254:growth & development / Q000503:physiopathology; D011247:Pregnancy; D011248:Pregnancy Complications / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D011295:Prenatal Care; D011297:Prenatal Exposure Delayed Effects; D012720:Severity of Illness Index; D013972:Thyrotropin / Q000097:blood; D013974:Thyroxine / Q000097:blood / Q000172:deficiency*; D016896:Treatment Outcome
D013972:Thyrotropin; D007455:Iodine; D013974:Thyroxine